GoodFish closed a $4 million Series A investment round, led by AF Ventures and Siddhi Capital, which will allow it to meet production demands, strengthen its R&D capability, and accelerate product innovation.
100% traceable salmon skin snack that reclaims Wild Alaskan Sockeye salmon skins. Image courtesy of GoodFish
GoodFish (Los Angeles, CA) closed a $4 million Series A investment round, led by AF Ventures and Siddhi Capital, which will allow it to meet production demands, strengthen its R&D capability, and accelerate product innovation. Goodfish launched in March 2020 as a 100% traceable salmon skin snack that reclaims Wild Alaskan Sockeye salmon skins that would otherwise go to waste from Bristol Bay, Alaska.
“The close of this round is an important step for us,” said Justin Guilbert, co-founder and chairman of GoodFish, in a press release. “We closed a pre-launch seed round less than a year ago and the pandemic pushed us into an online-only release in March. Against all odds, this distribution strategy paid off well above expectations and we’ve reached milestones way ahead of plan, this in turn required an earlier than anticipated fundraise. Our venture capital and operations partners recognized this very promising early signal and we’re thrilled to have them by our side as we gear up for rapid expansion.”
Douglas Riboud, CEO & co-founder, added: “It’s a great sign when your operations partner’s VC fund (Siddhi Capital) and your historical investor (AF Ventures) want to lead your next round. We’re doing something right and our innovative value proposition is resonating instantly with our core customers: those who believe that responsible and healthy can be affordable and yummy.”
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.